How do I order a Hepatitis B (HB) titer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Order a Hepatitis B Titer

To order a Hepatitis B titer, request a quantitative Hepatitis B surface antibody (anti-HBs) test, which should be performed 1-2 months after completing the vaccination series to determine immunity status. 1

Understanding Hepatitis B Titers

A Hepatitis B titer measures the level of antibodies against the Hepatitis B surface antigen (anti-HBs) in the blood. This test is used to:

  • Determine if a person has developed immunity after vaccination
  • Assess the need for revaccination or booster doses
  • Evaluate immunity status before potential exposure (especially for healthcare workers)

Specific Test to Order

When ordering a Hepatitis B titer, specify:

  • Quantitative Hepatitis B surface antibody (anti-HBs)
  • Request results in mIU/mL (international units)

When to Order Hepatitis B Titers

Hepatitis B titers should be ordered in the following situations:

  • 1-2 months after completing the Hepatitis B vaccination series 1
  • For healthcare personnel (HCP) upon hire or matriculation 1
  • For specific high-risk populations:
    • Hemodialysis patients (annually) 1
    • Immunocompromised persons 1
    • After exposure to HBV-positive blood or body fluids 1

Interpreting Results

  • Anti-HBs ≥10 mIU/mL: Considered protective (immune) 1
  • Anti-HBs <10 mIU/mL: Not protective (non-immune) 1

Follow-up Actions Based on Results

For immunocompetent persons:

  • Anti-HBs ≥10 mIU/mL: No further testing or vaccination needed 1, 2
  • Anti-HBs <10 mIU/mL after primary series: Revaccination recommended 1

For healthcare workers:

  • Anti-HBs <10 mIU/mL: Administer one additional dose of HepB vaccine, followed by anti-HBs testing 1-2 months later 1
  • If anti-HBs remains <10 mIU/mL: Complete a second series (total of 6 doses), followed by repeat testing 1

For hemodialysis patients:

  • Annual anti-HBs testing recommended 1
  • Booster dose when anti-HBs levels decline to <10 mIU/mL 1, 2

For immunocompromised persons:

  • Consider annual anti-HBs testing and booster doses 1, 2

Important Considerations

  • Different assays may have different cutoff values, so refer to the specific test's package insert for accurate interpretation 1
  • For post-exposure testing, timing is critical - testing should be performed 1-2 months after vaccination 1
  • For healthcare workers who received HBIG (Hepatitis B Immune Globulin), anti-HBs testing should be delayed until HBIG is no longer detectable (approximately 6 months) 1

Common Pitfalls to Avoid

  • Ordering the wrong test: Don't confuse anti-HBs (surface antibody) with HBsAg (surface antigen) or anti-HBc (core antibody)
  • Testing too early: Testing before 1-2 months after vaccination may not accurately reflect immunity
  • Unnecessary testing: Routine periodic testing is not recommended for immunocompetent persons who have documented immunity 1, 2, 3
  • Misinterpreting declining antibody levels: In immunocompetent individuals, protection persists even when antibody levels fall below 10 mIU/mL due to immunologic memory 2, 3

By following these guidelines, you can appropriately order and interpret Hepatitis B titers to ensure proper immunity assessment and management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis B Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.